nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—kidney cancer	0.216	1	CbGaD
Flurazepam—SLC22A2—Vinblastine—kidney cancer	0.0641	0.132	CbGbCtD
Flurazepam—ABCB1—Temsirolimus—kidney cancer	0.0567	0.116	CbGbCtD
Flurazepam—CYP3A4—Everolimus—kidney cancer	0.0503	0.103	CbGbCtD
Flurazepam—CYP3A4—Temsirolimus—kidney cancer	0.034	0.0697	CbGbCtD
Flurazepam—ABCB1—Pazopanib—kidney cancer	0.0298	0.0611	CbGbCtD
Flurazepam—ABCB1—Dactinomycin—kidney cancer	0.0272	0.0559	CbGbCtD
Flurazepam—ABCB1—Gemcitabine—kidney cancer	0.0215	0.0442	CbGbCtD
Flurazepam—ABCB1—Erlotinib—kidney cancer	0.0213	0.0436	CbGbCtD
Flurazepam—ABCB1—Paclitaxel—kidney cancer	0.0195	0.0399	CbGbCtD
Flurazepam—CYP3A4—Pazopanib—kidney cancer	0.0178	0.0366	CbGbCtD
Flurazepam—ABCB1—Sorafenib—kidney cancer	0.0173	0.0354	CbGbCtD
Flurazepam—ABCB1—Vinblastine—kidney cancer	0.0171	0.035	CbGbCtD
Flurazepam—ABCB1—Vincristine—kidney cancer	0.0168	0.0344	CbGbCtD
Flurazepam—ABCB1—Sunitinib—kidney cancer	0.014	0.0287	CbGbCtD
Flurazepam—CYP3A4—Erlotinib—kidney cancer	0.0127	0.0261	CbGbCtD
Flurazepam—CYP3A4—Paclitaxel—kidney cancer	0.0117	0.0239	CbGbCtD
Flurazepam—ABCB1—Doxorubicin—kidney cancer	0.0105	0.0215	CbGbCtD
Flurazepam—CYP3A4—Sorafenib—kidney cancer	0.0104	0.0212	CbGbCtD
Flurazepam—CYP3A4—Vinblastine—kidney cancer	0.0102	0.021	CbGbCtD
Flurazepam—CYP3A4—Vincristine—kidney cancer	0.0101	0.0206	CbGbCtD
Flurazepam—CYP3A4—Sunitinib—kidney cancer	0.00839	0.0172	CbGbCtD
Flurazepam—CYP3A4—Doxorubicin—kidney cancer	0.00628	0.0129	CbGbCtD
Flurazepam—SLC22A2—nephron—kidney cancer	0.00253	0.294	CbGeAlD
Flurazepam—Amodiaquine—CYP1A1—kidney cancer	0.000899	0.224	CrCbGaD
Flurazepam—CYP2E1—urine—kidney cancer	0.000811	0.0943	CbGeAlD
Flurazepam—CYP3A4—urine—kidney cancer	0.000653	0.0759	CbGeAlD
Flurazepam—Chloroquine—CYP1A1—kidney cancer	0.00065	0.162	CrCbGaD
Flurazepam—Constipation—Everolimus—kidney cancer	0.000553	0.00267	CcSEcCtD
Flurazepam—Vomiting—Temsirolimus—kidney cancer	0.000553	0.00267	CcSEcCtD
Flurazepam—Shock—Sorafenib—kidney cancer	0.000553	0.00267	CcSEcCtD
Flurazepam—Gait disturbance—Doxorubicin—kidney cancer	0.000552	0.00266	CcSEcCtD
Flurazepam—Dry mouth—Sunitinib—kidney cancer	0.000551	0.00266	CcSEcCtD
Flurazepam—Dyspepsia—Erlotinib—kidney cancer	0.00055	0.00265	CcSEcCtD
Flurazepam—Rash—Temsirolimus—kidney cancer	0.000548	0.00265	CcSEcCtD
Flurazepam—Dermatitis—Temsirolimus—kidney cancer	0.000548	0.00264	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.000546	0.00263	CcSEcCtD
Flurazepam—SLC22A2—nephron tubule—kidney cancer	0.000546	0.0634	CbGeAlD
Flurazepam—Headache—Temsirolimus—kidney cancer	0.000545	0.00263	CcSEcCtD
Flurazepam—Decreased appetite—Erlotinib—kidney cancer	0.000543	0.00262	CcSEcCtD
Flurazepam—Dizziness—Pazopanib—kidney cancer	0.000542	0.00262	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Doxorubicin—kidney cancer	0.000538	0.0026	CcSEcCtD
Flurazepam—Anorexia—Sorafenib—kidney cancer	0.000535	0.00258	CcSEcCtD
Flurazepam—Feeling abnormal—Vinblastine—kidney cancer	0.000535	0.00258	CcSEcCtD
Flurazepam—Constipation—Erlotinib—kidney cancer	0.000534	0.00258	CcSEcCtD
Flurazepam—Feeling abnormal—Everolimus—kidney cancer	0.000533	0.00257	CcSEcCtD
Flurazepam—Shock—Sunitinib—kidney cancer	0.000532	0.00257	CcSEcCtD
Flurazepam—Gastrointestinal pain—Vinblastine—kidney cancer	0.000531	0.00256	CcSEcCtD
Flurazepam—Gastrointestinal pain—Everolimus—kidney cancer	0.000529	0.00255	CcSEcCtD
Flurazepam—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000523	0.00252	CcSEcCtD
Flurazepam—Vomiting—Pazopanib—kidney cancer	0.000521	0.00251	CcSEcCtD
Flurazepam—Rash—Pazopanib—kidney cancer	0.000517	0.00249	CcSEcCtD
Flurazepam—Nausea—Temsirolimus—kidney cancer	0.000517	0.00249	CcSEcCtD
Flurazepam—Dermatitis—Pazopanib—kidney cancer	0.000516	0.00249	CcSEcCtD
Flurazepam—Anorexia—Sunitinib—kidney cancer	0.000515	0.00249	CcSEcCtD
Flurazepam—Agitation—Vincristine—kidney cancer	0.000515	0.00248	CcSEcCtD
Flurazepam—Headache—Pazopanib—kidney cancer	0.000513	0.00248	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000512	0.00247	CcSEcCtD
Flurazepam—Clomipramine—GSTP1—kidney cancer	0.000511	0.128	CrCbGaD
Flurazepam—Gastrointestinal pain—Erlotinib—kidney cancer	0.00051	0.00246	CcSEcCtD
Flurazepam—Abdominal discomfort—Capecitabine—kidney cancer	0.000502	0.00242	CcSEcCtD
Flurazepam—Leukopenia—Vincristine—kidney cancer	0.000501	0.00242	CcSEcCtD
Flurazepam—Dyspnoea—Sorafenib—kidney cancer	0.000501	0.00242	CcSEcCtD
Flurazepam—SLC22A2—renal system—kidney cancer	0.000496	0.0577	CbGeAlD
Flurazepam—Dyspepsia—Sorafenib—kidney cancer	0.000494	0.00239	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000492	0.00238	CcSEcCtD
Flurazepam—Coma—Doxorubicin—kidney cancer	0.000492	0.00237	CcSEcCtD
Flurazepam—Decreased appetite—Sorafenib—kidney cancer	0.000488	0.00236	CcSEcCtD
Flurazepam—Anorexia—Dactinomycin—kidney cancer	0.000488	0.00235	CcSEcCtD
Flurazepam—Nausea—Pazopanib—kidney cancer	0.000487	0.00235	CcSEcCtD
Flurazepam—Dyspnoea—Sunitinib—kidney cancer	0.000482	0.00233	CcSEcCtD
Flurazepam—Constipation—Sorafenib—kidney cancer	0.00048	0.00232	CcSEcCtD
Flurazepam—SLC22A2—kidney—kidney cancer	0.00048	0.0558	CbGeAlD
Flurazepam—Dyspepsia—Sunitinib—kidney cancer	0.000476	0.0023	CcSEcCtD
Flurazepam—Leukopenia—Gemcitabine—kidney cancer	0.000476	0.0023	CcSEcCtD
Flurazepam—Flushing—Paclitaxel—kidney cancer	0.000474	0.00229	CcSEcCtD
Flurazepam—Decreased appetite—Sunitinib—kidney cancer	0.00047	0.00227	CcSEcCtD
Flurazepam—Mental disability—Doxorubicin—kidney cancer	0.000467	0.00225	CcSEcCtD
Flurazepam—SLC22A2—cortex of kidney—kidney cancer	0.000467	0.0543	CbGeAlD
Flurazepam—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000466	0.00225	CcSEcCtD
Flurazepam—Asthenia—Vinblastine—kidney cancer	0.000466	0.00225	CcSEcCtD
Flurazepam—Asthenia—Everolimus—kidney cancer	0.000464	0.00224	CcSEcCtD
Flurazepam—Constipation—Sunitinib—kidney cancer	0.000462	0.00223	CcSEcCtD
Flurazepam—Gastrointestinal pain—Sorafenib—kidney cancer	0.000459	0.00222	CcSEcCtD
Flurazepam—Pruritus—Everolimus—kidney cancer	0.000458	0.00221	CcSEcCtD
Flurazepam—Anaphylactic shock—Vincristine—kidney cancer	0.000457	0.00221	CcSEcCtD
Flurazepam—Chest pain—Gemcitabine—kidney cancer	0.000452	0.00218	CcSEcCtD
Flurazepam—Arthralgia—Gemcitabine—kidney cancer	0.000452	0.00218	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000449	0.00217	CcSEcCtD
Flurazepam—Asthenia—Erlotinib—kidney cancer	0.000448	0.00216	CcSEcCtD
Flurazepam—Decreased appetite—Dactinomycin—kidney cancer	0.000445	0.00215	CcSEcCtD
Flurazepam—Diarrhoea—Vinblastine—kidney cancer	0.000444	0.00214	CcSEcCtD
Flurazepam—Diarrhoea—Everolimus—kidney cancer	0.000443	0.00214	CcSEcCtD
Flurazepam—Gastrointestinal pain—Sunitinib—kidney cancer	0.000442	0.00213	CcSEcCtD
Flurazepam—Hyperhidrosis—Vincristine—kidney cancer	0.000442	0.00213	CcSEcCtD
Flurazepam—Pruritus—Erlotinib—kidney cancer	0.000442	0.00213	CcSEcCtD
Flurazepam—Tension—Paclitaxel—kidney cancer	0.000437	0.00211	CcSEcCtD
Flurazepam—Agranulocytosis—Capecitabine—kidney cancer	0.000436	0.0021	CcSEcCtD
Flurazepam—Anorexia—Vincristine—kidney cancer	0.000436	0.0021	CcSEcCtD
Flurazepam—Dysgeusia—Paclitaxel—kidney cancer	0.000436	0.0021	CcSEcCtD
Flurazepam—Anaphylactic shock—Gemcitabine—kidney cancer	0.000434	0.00209	CcSEcCtD
Flurazepam—Nervousness—Paclitaxel—kidney cancer	0.000432	0.00209	CcSEcCtD
Flurazepam—Dizziness—Vinblastine—kidney cancer	0.000429	0.00207	CcSEcCtD
Flurazepam—Dizziness—Everolimus—kidney cancer	0.000428	0.00206	CcSEcCtD
Flurazepam—Diarrhoea—Erlotinib—kidney cancer	0.000427	0.00206	CcSEcCtD
Flurazepam—Hypotension—Vincristine—kidney cancer	0.000427	0.00206	CcSEcCtD
Flurazepam—Feeling abnormal—Dactinomycin—kidney cancer	0.000422	0.00203	CcSEcCtD
Flurazepam—Vision blurred—Paclitaxel—kidney cancer	0.000419	0.00202	CcSEcCtD
Flurazepam—Hyperhidrosis—Gemcitabine—kidney cancer	0.000419	0.00202	CcSEcCtD
Flurazepam—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000418	0.00202	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000416	0.00201	CcSEcCtD
Flurazepam—Anorexia—Gemcitabine—kidney cancer	0.000413	0.00199	CcSEcCtD
Flurazepam—Vomiting—Vinblastine—kidney cancer	0.000413	0.00199	CcSEcCtD
Flurazepam—Dizziness—Erlotinib—kidney cancer	0.000413	0.00199	CcSEcCtD
Flurazepam—Vomiting—Everolimus—kidney cancer	0.000411	0.00199	CcSEcCtD
Flurazepam—Agitation—Paclitaxel—kidney cancer	0.000409	0.00197	CcSEcCtD
Flurazepam—Rash—Everolimus—kidney cancer	0.000408	0.00197	CcSEcCtD
Flurazepam—Dermatitis—Everolimus—kidney cancer	0.000408	0.00197	CcSEcCtD
Flurazepam—Headache—Vinblastine—kidney cancer	0.000407	0.00196	CcSEcCtD
Flurazepam—Headache—Everolimus—kidney cancer	0.000405	0.00196	CcSEcCtD
Flurazepam—Hypotension—Gemcitabine—kidney cancer	0.000405	0.00196	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000404	0.00195	CcSEcCtD
Flurazepam—Asthenia—Sorafenib—kidney cancer	0.000403	0.00194	CcSEcCtD
Flurazepam—Syncope—Paclitaxel—kidney cancer	0.000399	0.00193	CcSEcCtD
Flurazepam—Lethargy—Doxorubicin—kidney cancer	0.000399	0.00192	CcSEcCtD
Flurazepam—Leukopenia—Paclitaxel—kidney cancer	0.000398	0.00192	CcSEcCtD
Flurazepam—Decreased appetite—Vincristine—kidney cancer	0.000397	0.00192	CcSEcCtD
Flurazepam—Pruritus—Sorafenib—kidney cancer	0.000397	0.00192	CcSEcCtD
Flurazepam—Vomiting—Erlotinib—kidney cancer	0.000397	0.00192	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000395	0.00191	CcSEcCtD
Flurazepam—Rash—Erlotinib—kidney cancer	0.000394	0.0019	CcSEcCtD
Flurazepam—Dermatitis—Erlotinib—kidney cancer	0.000393	0.0019	CcSEcCtD
Flurazepam—Palpitations—Paclitaxel—kidney cancer	0.000393	0.0019	CcSEcCtD
Flurazepam—Headache—Erlotinib—kidney cancer	0.000391	0.00189	CcSEcCtD
Flurazepam—Loss of consciousness—Paclitaxel—kidney cancer	0.000391	0.00189	CcSEcCtD
Flurazepam—Constipation—Vincristine—kidney cancer	0.000391	0.00189	CcSEcCtD
Flurazepam—Quinacrine—ABCB1—kidney cancer	0.00039	0.0972	CrCbGaD
Flurazepam—Flushing—Capecitabine—kidney cancer	0.000389	0.00188	CcSEcCtD
Flurazepam—Asthenia—Sunitinib—kidney cancer	0.000388	0.00187	CcSEcCtD
Flurazepam—Dyspnoea—Gemcitabine—kidney cancer	0.000387	0.00187	CcSEcCtD
Flurazepam—Nausea—Vinblastine—kidney cancer	0.000386	0.00186	CcSEcCtD
Flurazepam—Somnolence—Gemcitabine—kidney cancer	0.000385	0.00186	CcSEcCtD
Flurazepam—Nausea—Everolimus—kidney cancer	0.000384	0.00185	CcSEcCtD
Flurazepam—Diarrhoea—Sorafenib—kidney cancer	0.000384	0.00185	CcSEcCtD
Flurazepam—Pruritus—Sunitinib—kidney cancer	0.000382	0.00185	CcSEcCtD
Flurazepam—Arthralgia—Paclitaxel—kidney cancer	0.000379	0.00183	CcSEcCtD
Flurazepam—Chest pain—Paclitaxel—kidney cancer	0.000379	0.00183	CcSEcCtD
Flurazepam—Anxiety—Paclitaxel—kidney cancer	0.000377	0.00182	CcSEcCtD
Flurazepam—Decreased appetite—Gemcitabine—kidney cancer	0.000377	0.00182	CcSEcCtD
Flurazepam—Gastrointestinal pain—Vincristine—kidney cancer	0.000374	0.0018	CcSEcCtD
Flurazepam—Dizziness—Sorafenib—kidney cancer	0.000371	0.00179	CcSEcCtD
Flurazepam—Constipation—Gemcitabine—kidney cancer	0.000371	0.00179	CcSEcCtD
Flurazepam—Nausea—Erlotinib—kidney cancer	0.000371	0.00179	CcSEcCtD
Flurazepam—Dry mouth—Paclitaxel—kidney cancer	0.00037	0.00179	CcSEcCtD
Flurazepam—Diarrhoea—Sunitinib—kidney cancer	0.00037	0.00178	CcSEcCtD
Flurazepam—Ataxia—Doxorubicin—kidney cancer	0.000367	0.00177	CcSEcCtD
Flurazepam—Asthenia—Dactinomycin—kidney cancer	0.000367	0.00177	CcSEcCtD
Flurazepam—Confusional state—Paclitaxel—kidney cancer	0.000366	0.00177	CcSEcCtD
Flurazepam—Anaphylactic shock—Paclitaxel—kidney cancer	0.000363	0.00175	CcSEcCtD
Flurazepam—Dysgeusia—Capecitabine—kidney cancer	0.000357	0.00173	CcSEcCtD
Flurazepam—Dizziness—Sunitinib—kidney cancer	0.000357	0.00172	CcSEcCtD
Flurazepam—Feeling abnormal—Gemcitabine—kidney cancer	0.000357	0.00172	CcSEcCtD
Flurazepam—Shock—Paclitaxel—kidney cancer	0.000357	0.00172	CcSEcCtD
Flurazepam—Vomiting—Sorafenib—kidney cancer	0.000357	0.00172	CcSEcCtD
Flurazepam—Rash—Sorafenib—kidney cancer	0.000354	0.00171	CcSEcCtD
Flurazepam—Dermatitis—Sorafenib—kidney cancer	0.000354	0.00171	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000352	0.0017	CcSEcCtD
Flurazepam—Headache—Sorafenib—kidney cancer	0.000352	0.0017	CcSEcCtD
Flurazepam—Hyperhidrosis—Paclitaxel—kidney cancer	0.000351	0.00169	CcSEcCtD
Flurazepam—Diarrhoea—Dactinomycin—kidney cancer	0.00035	0.00169	CcSEcCtD
Flurazepam—GABRA2—cortex of kidney—kidney cancer	0.000349	0.0406	CbGeAlD
Flurazepam—Anorexia—Paclitaxel—kidney cancer	0.000346	0.00167	CcSEcCtD
Flurazepam—Chloroquine—ABCB1—kidney cancer	0.000345	0.0862	CrCbGaD
Flurazepam—Vision blurred—Capecitabine—kidney cancer	0.000344	0.00166	CcSEcCtD
Flurazepam—Vomiting—Sunitinib—kidney cancer	0.000344	0.00166	CcSEcCtD
Flurazepam—Rash—Sunitinib—kidney cancer	0.000341	0.00164	CcSEcCtD
Flurazepam—Dermatitis—Sunitinib—kidney cancer	0.00034	0.00164	CcSEcCtD
Flurazepam—Hypotension—Paclitaxel—kidney cancer	0.000339	0.00164	CcSEcCtD
Flurazepam—Headache—Sunitinib—kidney cancer	0.000339	0.00163	CcSEcCtD
Flurazepam—Nausea—Sorafenib—kidney cancer	0.000334	0.00161	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000331	0.0016	CcSEcCtD
Flurazepam—GABRE—cardiac atrium—kidney cancer	0.00033	0.0383	CbGeAlD
Flurazepam—Asthenia—Vincristine—kidney cancer	0.000328	0.00158	CcSEcCtD
Flurazepam—Syncope—Capecitabine—kidney cancer	0.000327	0.00158	CcSEcCtD
Flurazepam—Leukopenia—Capecitabine—kidney cancer	0.000327	0.00158	CcSEcCtD
Flurazepam—Vomiting—Dactinomycin—kidney cancer	0.000325	0.00157	CcSEcCtD
Flurazepam—Dyspnoea—Paclitaxel—kidney cancer	0.000324	0.00156	CcSEcCtD
Flurazepam—Somnolence—Paclitaxel—kidney cancer	0.000323	0.00156	CcSEcCtD
Flurazepam—Palpitations—Capecitabine—kidney cancer	0.000323	0.00156	CcSEcCtD
Flurazepam—Rash—Dactinomycin—kidney cancer	0.000323	0.00156	CcSEcCtD
Flurazepam—Nausea—Sunitinib—kidney cancer	0.000321	0.00155	CcSEcCtD
Flurazepam—Loss of consciousness—Capecitabine—kidney cancer	0.000321	0.00155	CcSEcCtD
Flurazepam—Dyspepsia—Paclitaxel—kidney cancer	0.00032	0.00154	CcSEcCtD
Flurazepam—Decreased appetite—Paclitaxel—kidney cancer	0.000316	0.00152	CcSEcCtD
Flurazepam—Diarrhoea—Vincristine—kidney cancer	0.000313	0.00151	CcSEcCtD
Flurazepam—Asthenia—Gemcitabine—kidney cancer	0.000311	0.0015	CcSEcCtD
Flurazepam—Arthralgia—Capecitabine—kidney cancer	0.000311	0.0015	CcSEcCtD
Flurazepam—Chest pain—Capecitabine—kidney cancer	0.000311	0.0015	CcSEcCtD
Flurazepam—Constipation—Paclitaxel—kidney cancer	0.00031	0.0015	CcSEcCtD
Flurazepam—Anxiety—Capecitabine—kidney cancer	0.00031	0.00149	CcSEcCtD
Flurazepam—Pruritus—Gemcitabine—kidney cancer	0.000307	0.00148	CcSEcCtD
Flurazepam—Dry mouth—Capecitabine—kidney cancer	0.000304	0.00147	CcSEcCtD
Flurazepam—Nausea—Dactinomycin—kidney cancer	0.000304	0.00147	CcSEcCtD
Flurazepam—Dizziness—Vincristine—kidney cancer	0.000302	0.00146	CcSEcCtD
Flurazepam—Drowsiness—Doxorubicin—kidney cancer	0.000301	0.00145	CcSEcCtD
Flurazepam—Confusional state—Capecitabine—kidney cancer	0.0003	0.00145	CcSEcCtD
Flurazepam—Feeling abnormal—Paclitaxel—kidney cancer	0.000299	0.00144	CcSEcCtD
Flurazepam—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000297	0.00143	CcSEcCtD
Flurazepam—Diarrhoea—Gemcitabine—kidney cancer	0.000297	0.00143	CcSEcCtD
Flurazepam—Shock—Capecitabine—kidney cancer	0.000293	0.00141	CcSEcCtD
Flurazepam—Vomiting—Vincristine—kidney cancer	0.000291	0.0014	CcSEcCtD
Flurazepam—Sweating—Doxorubicin—kidney cancer	0.000289	0.00139	CcSEcCtD
Flurazepam—Rash—Vincristine—kidney cancer	0.000288	0.00139	CcSEcCtD
Flurazepam—Hyperhidrosis—Capecitabine—kidney cancer	0.000288	0.00139	CcSEcCtD
Flurazepam—Dermatitis—Vincristine—kidney cancer	0.000288	0.00139	CcSEcCtD
Flurazepam—Headache—Vincristine—kidney cancer	0.000286	0.00138	CcSEcCtD
Flurazepam—Anorexia—Capecitabine—kidney cancer	0.000284	0.00137	CcSEcCtD
Flurazepam—Agranulocytosis—Doxorubicin—kidney cancer	0.000281	0.00136	CcSEcCtD
Flurazepam—GABRB3—gonad—kidney cancer	0.00028	0.0325	CbGeAlD
Flurazepam—Hypotension—Capecitabine—kidney cancer	0.000278	0.00134	CcSEcCtD
Flurazepam—Vomiting—Gemcitabine—kidney cancer	0.000276	0.00133	CcSEcCtD
Flurazepam—Rash—Gemcitabine—kidney cancer	0.000273	0.00132	CcSEcCtD
Flurazepam—Dermatitis—Gemcitabine—kidney cancer	0.000273	0.00132	CcSEcCtD
Flurazepam—Headache—Gemcitabine—kidney cancer	0.000272	0.00131	CcSEcCtD
Flurazepam—Nausea—Vincristine—kidney cancer	0.000272	0.00131	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000271	0.00131	CcSEcCtD
Flurazepam—Dyspnoea—Capecitabine—kidney cancer	0.000266	0.00128	CcSEcCtD
Flurazepam—Dyspepsia—Capecitabine—kidney cancer	0.000262	0.00127	CcSEcCtD
Flurazepam—Asthenia—Paclitaxel—kidney cancer	0.00026	0.00126	CcSEcCtD
Flurazepam—Decreased appetite—Capecitabine—kidney cancer	0.000259	0.00125	CcSEcCtD
Flurazepam—Nausea—Gemcitabine—kidney cancer	0.000258	0.00124	CcSEcCtD
Flurazepam—Pruritus—Paclitaxel—kidney cancer	0.000257	0.00124	CcSEcCtD
Flurazepam—Constipation—Capecitabine—kidney cancer	0.000255	0.00123	CcSEcCtD
Flurazepam—Flushing—Doxorubicin—kidney cancer	0.000251	0.00121	CcSEcCtD
Flurazepam—Diarrhoea—Paclitaxel—kidney cancer	0.000248	0.0012	CcSEcCtD
Flurazepam—Feeling abnormal—Capecitabine—kidney cancer	0.000246	0.00118	CcSEcCtD
Flurazepam—Gastrointestinal pain—Capecitabine—kidney cancer	0.000244	0.00118	CcSEcCtD
Flurazepam—Chlorpromazine—BCHE—kidney cancer	0.000241	0.0601	CrCbGaD
Flurazepam—Dizziness—Paclitaxel—kidney cancer	0.00024	0.00116	CcSEcCtD
Flurazepam—Tension—Doxorubicin—kidney cancer	0.000231	0.00111	CcSEcCtD
Flurazepam—Vomiting—Paclitaxel—kidney cancer	0.000231	0.00111	CcSEcCtD
Flurazepam—Dysgeusia—Doxorubicin—kidney cancer	0.00023	0.00111	CcSEcCtD
Flurazepam—Rash—Paclitaxel—kidney cancer	0.000229	0.0011	CcSEcCtD
Flurazepam—Dermatitis—Paclitaxel—kidney cancer	0.000229	0.0011	CcSEcCtD
Flurazepam—Nervousness—Doxorubicin—kidney cancer	0.000229	0.0011	CcSEcCtD
Flurazepam—Headache—Paclitaxel—kidney cancer	0.000227	0.0011	CcSEcCtD
Flurazepam—Vision blurred—Doxorubicin—kidney cancer	0.000222	0.00107	CcSEcCtD
Flurazepam—CYP2E1—nephron tubule—kidney cancer	0.000218	0.0254	CbGeAlD
Flurazepam—Agitation—Doxorubicin—kidney cancer	0.000216	0.00104	CcSEcCtD
Flurazepam—Nausea—Paclitaxel—kidney cancer	0.000216	0.00104	CcSEcCtD
Flurazepam—Asthenia—Capecitabine—kidney cancer	0.000214	0.00103	CcSEcCtD
Flurazepam—Syncope—Doxorubicin—kidney cancer	0.000211	0.00102	CcSEcCtD
Flurazepam—Pruritus—Capecitabine—kidney cancer	0.000211	0.00102	CcSEcCtD
Flurazepam—Leukopenia—Doxorubicin—kidney cancer	0.000211	0.00102	CcSEcCtD
Flurazepam—Diazepam—PTGS1—kidney cancer	0.000209	0.0521	CrCbGaD
Flurazepam—Palpitations—Doxorubicin—kidney cancer	0.000208	0.001	CcSEcCtD
Flurazepam—Loss of consciousness—Doxorubicin—kidney cancer	0.000207	0.000998	CcSEcCtD
Flurazepam—Diarrhoea—Capecitabine—kidney cancer	0.000204	0.000984	CcSEcCtD
Flurazepam—Arthralgia—Doxorubicin—kidney cancer	0.0002	0.000967	CcSEcCtD
Flurazepam—Chest pain—Doxorubicin—kidney cancer	0.0002	0.000967	CcSEcCtD
Flurazepam—Anxiety—Doxorubicin—kidney cancer	0.0002	0.000964	CcSEcCtD
Flurazepam—CYP2E1—renal system—kidney cancer	0.000198	0.0231	CbGeAlD
Flurazepam—Dizziness—Capecitabine—kidney cancer	0.000197	0.000951	CcSEcCtD
Flurazepam—Dry mouth—Doxorubicin—kidney cancer	0.000196	0.000946	CcSEcCtD
Flurazepam—Confusional state—Doxorubicin—kidney cancer	0.000194	0.000935	CcSEcCtD
Flurazepam—Anaphylactic shock—Doxorubicin—kidney cancer	0.000192	0.000927	CcSEcCtD
Flurazepam—CYP2E1—kidney—kidney cancer	0.000192	0.0223	CbGeAlD
Flurazepam—Vomiting—Capecitabine—kidney cancer	0.000189	0.000914	CcSEcCtD
Flurazepam—Shock—Doxorubicin—kidney cancer	0.000189	0.000912	CcSEcCtD
Flurazepam—Rash—Capecitabine—kidney cancer	0.000188	0.000907	CcSEcCtD
Flurazepam—Dermatitis—Capecitabine—kidney cancer	0.000188	0.000906	CcSEcCtD
Flurazepam—CYP2E1—cortex of kidney—kidney cancer	0.000187	0.0217	CbGeAlD
Flurazepam—Headache—Capecitabine—kidney cancer	0.000187	0.000901	CcSEcCtD
Flurazepam—Hyperhidrosis—Doxorubicin—kidney cancer	0.000186	0.000896	CcSEcCtD
Flurazepam—Anorexia—Doxorubicin—kidney cancer	0.000183	0.000884	CcSEcCtD
Flurazepam—Hypotension—Doxorubicin—kidney cancer	0.000179	0.000866	CcSEcCtD
Flurazepam—Nausea—Capecitabine—kidney cancer	0.000177	0.000854	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000175	0.000844	CcSEcCtD
Flurazepam—Clobazam—ABCB1—kidney cancer	0.000174	0.0434	CrCbGaD
Flurazepam—Dyspnoea—Doxorubicin—kidney cancer	0.000171	0.000826	CcSEcCtD
Flurazepam—Somnolence—Doxorubicin—kidney cancer	0.000171	0.000824	CcSEcCtD
Flurazepam—Dyspepsia—Doxorubicin—kidney cancer	0.000169	0.000816	CcSEcCtD
Flurazepam—Decreased appetite—Doxorubicin—kidney cancer	0.000167	0.000806	CcSEcCtD
Flurazepam—Constipation—Doxorubicin—kidney cancer	0.000164	0.000793	CcSEcCtD
Flurazepam—CYP3A4—renal system—kidney cancer	0.00016	0.0186	CbGeAlD
Flurazepam—Feeling abnormal—Doxorubicin—kidney cancer	0.000158	0.000764	CcSEcCtD
Flurazepam—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000157	0.000758	CcSEcCtD
Flurazepam—CYP3A4—kidney—kidney cancer	0.000154	0.0179	CbGeAlD
Flurazepam—Asthenia—Doxorubicin—kidney cancer	0.000138	0.000665	CcSEcCtD
Flurazepam—Clomipramine—ABCB1—kidney cancer	0.000138	0.0343	CrCbGaD
Flurazepam—Chlorprothixene—ABCB1—kidney cancer	0.000137	0.0342	CrCbGaD
Flurazepam—Pruritus—Doxorubicin—kidney cancer	0.000136	0.000656	CcSEcCtD
Flurazepam—Diarrhoea—Doxorubicin—kidney cancer	0.000131	0.000634	CcSEcCtD
Flurazepam—Dizziness—Doxorubicin—kidney cancer	0.000127	0.000613	CcSEcCtD
Flurazepam—ABCB1—nephron tubule—kidney cancer	0.000124	0.0145	CbGeAlD
Flurazepam—Vomiting—Doxorubicin—kidney cancer	0.000122	0.000589	CcSEcCtD
Flurazepam—Rash—Doxorubicin—kidney cancer	0.000121	0.000584	CcSEcCtD
Flurazepam—Dermatitis—Doxorubicin—kidney cancer	0.000121	0.000584	CcSEcCtD
Flurazepam—Headache—Doxorubicin—kidney cancer	0.00012	0.000581	CcSEcCtD
Flurazepam—Midazolam—ABCB1—kidney cancer	0.000119	0.0296	CrCbGaD
Flurazepam—Nausea—Doxorubicin—kidney cancer	0.000114	0.000551	CcSEcCtD
Flurazepam—ABCB1—renal system—kidney cancer	0.000113	0.0131	CbGeAlD
Flurazepam—ABCB1—kidney—kidney cancer	0.000109	0.0127	CbGeAlD
Flurazepam—ABCB1—cortex of kidney—kidney cancer	0.000106	0.0124	CbGeAlD
Flurazepam—Diazepam—ABCB1—kidney cancer	0.000102	0.0253	CrCbGaD
Flurazepam—ABCB1—gonad—kidney cancer	0.000101	0.0118	CbGeAlD
Flurazepam—Chlorpromazine—ABCB1—kidney cancer	9.43e-05	0.0235	CrCbGaD
Flurazepam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.89e-05	0.000506	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.88e-05	0.000505	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—RAF1—kidney cancer	3.85e-05	0.000502	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.85e-05	0.000501	CbGpPWpGaD
Flurazepam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.84e-05	0.0005	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.82e-05	0.000497	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	3.8e-05	0.000495	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—BRAF—kidney cancer	3.8e-05	0.000494	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—RAF1—kidney cancer	3.78e-05	0.000493	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PDHB—kidney cancer	3.78e-05	0.000493	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	3.78e-05	0.000492	CbGpPWpGaD
Flurazepam—CYP2E1—Biological oxidations—POMC—kidney cancer	3.77e-05	0.000491	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.77e-05	0.000491	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.76e-05	0.000489	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.76e-05	0.000489	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.76e-05	0.000489	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—RAF1—kidney cancer	3.72e-05	0.000484	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPC3—kidney cancer	3.72e-05	0.000484	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—RAF1—kidney cancer	3.7e-05	0.000481	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.66e-05	0.000477	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.64e-05	0.000474	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—FH—kidney cancer	3.63e-05	0.000472	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—APRT—kidney cancer	3.63e-05	0.000472	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.63e-05	0.000472	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—RAF1—kidney cancer	3.63e-05	0.000472	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CA2—kidney cancer	3.62e-05	0.000471	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.6e-05	0.000468	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CCBL1—kidney cancer	3.56e-05	0.000463	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.55e-05	0.000462	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.53e-05	0.00046	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALAD—kidney cancer	3.52e-05	0.000459	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.51e-05	0.000457	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.51e-05	0.000456	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—BRAF—kidney cancer	3.49e-05	0.000454	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.45e-05	0.000449	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.45e-05	0.000449	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ST3GAL2—kidney cancer	3.44e-05	0.000448	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPC3—kidney cancer	3.41e-05	0.000444	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.39e-05	0.000441	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ALDH1A1—kidney cancer	3.36e-05	0.000438	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ACY1—kidney cancer	3.35e-05	0.000436	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.33e-05	0.000433	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.33e-05	0.000433	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CA2—kidney cancer	3.32e-05	0.000432	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.31e-05	0.000431	CbGpPWpGaD
Flurazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.3e-05	0.000429	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.25e-05	0.000423	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALAD—kidney cancer	3.23e-05	0.000421	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—MAPK1—kidney cancer	3.23e-05	0.000421	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.23e-05	0.00042	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PGK1—kidney cancer	3.22e-05	0.00042	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC5A3—kidney cancer	3.22e-05	0.00042	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—MAPK1—kidney cancer	3.18e-05	0.000415	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—RAF1—kidney cancer	3.17e-05	0.000413	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—LDHB—kidney cancer	3.16e-05	0.000411	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ST3GAL2—kidney cancer	3.16e-05	0.000411	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ALDH1A1—kidney cancer	3.09e-05	0.000402	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GLIPR1—kidney cancer	3.09e-05	0.000402	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PPAT—kidney cancer	3.09e-05	0.000402	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.08e-05	0.000401	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—RAF1—kidney cancer	3.08e-05	0.000401	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.01e-05	0.000392	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—MAPK1—kidney cancer	3.01e-05	0.000392	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—MAPK1—kidney cancer	2.98e-05	0.000387	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC5A3—kidney cancer	2.96e-05	0.000385	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PGK1—kidney cancer	2.96e-05	0.000385	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—RAF1—kidney cancer	2.91e-05	0.000379	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—LDHB—kidney cancer	2.9e-05	0.000378	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—APRT—kidney cancer	2.87e-05	0.000373	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—FH—kidney cancer	2.87e-05	0.000373	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PDHB—kidney cancer	2.85e-05	0.000371	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.84e-05	0.00037	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.77e-05	0.00036	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.74e-05	0.000357	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CA9—kidney cancer	2.74e-05	0.000357	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—MAPK1—kidney cancer	2.72e-05	0.000354	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPC3—kidney cancer	2.7e-05	0.000351	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.69e-05	0.000351	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CCBL1—kidney cancer	2.68e-05	0.000349	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.66e-05	0.000346	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—MAPK1—kidney cancer	2.64e-05	0.000344	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CA2—kidney cancer	2.62e-05	0.000341	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.61e-05	0.000339	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—MAPK1—kidney cancer	2.6e-05	0.000338	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALAD—kidney cancer	2.56e-05	0.000333	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—MAPK1—kidney cancer	2.55e-05	0.000332	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—MAPK1—kidney cancer	2.53e-05	0.00033	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.53e-05	0.00033	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CA9—kidney cancer	2.52e-05	0.000327	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.5e-05	0.000325	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ST3GAL2—kidney cancer	2.5e-05	0.000325	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—MAPK1—kidney cancer	2.49e-05	0.000324	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.48e-05	0.000322	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.44e-05	0.000318	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ALDH1A1—kidney cancer	2.44e-05	0.000317	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.36e-05	0.000307	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.35e-05	0.000306	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC5A3—kidney cancer	2.34e-05	0.000304	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PGK1—kidney cancer	2.34e-05	0.000304	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.33e-05	0.000304	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CRABP1—kidney cancer	2.33e-05	0.000303	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GLIPR1—kidney cancer	2.32e-05	0.000302	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PPAT—kidney cancer	2.32e-05	0.000302	CbGpPWpGaD
Flurazepam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.32e-05	0.000301	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—LDHB—kidney cancer	2.29e-05	0.000298	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—MAPK1—kidney cancer	2.18e-05	0.000283	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ITPR2—kidney cancer	2.17e-05	0.000282	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—APRT—kidney cancer	2.16e-05	0.000281	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—FH—kidney cancer	2.16e-05	0.000281	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.15e-05	0.00028	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CRABP1—kidney cancer	2.14e-05	0.000278	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.13e-05	0.000278	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.13e-05	0.000277	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.08e-05	0.000271	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	2.07e-05	0.00027	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ACY1—kidney cancer	2.06e-05	0.000269	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.03e-05	0.000265	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPC3—kidney cancer	2.03e-05	0.000264	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	2e-05	0.00026	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—MAPK1—kidney cancer	2e-05	0.00026	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ITPR2—kidney cancer	1.99e-05	0.000259	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CA9—kidney cancer	1.99e-05	0.000259	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.99e-05	0.000259	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.98e-05	0.000258	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ACHE—kidney cancer	1.98e-05	0.000257	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTT1—kidney cancer	1.98e-05	0.000257	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CA2—kidney cancer	1.98e-05	0.000257	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.97e-05	0.000257	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.95e-05	0.000254	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALAD—kidney cancer	1.93e-05	0.000251	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.91e-05	0.000249	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.88e-05	0.000245	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.88e-05	0.000245	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.88e-05	0.000245	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SCARB1—kidney cancer	1.87e-05	0.000243	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.86e-05	0.000243	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS1—kidney cancer	1.85e-05	0.000241	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.84e-05	0.000239	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.82e-05	0.000237	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PSMD7—kidney cancer	1.82e-05	0.000236	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTT1—kidney cancer	1.81e-05	0.000236	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ACHE—kidney cancer	1.81e-05	0.000236	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PGK1—kidney cancer	1.76e-05	0.000229	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC5A3—kidney cancer	1.76e-05	0.000229	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PDHB—kidney cancer	1.76e-05	0.000229	CbGpPWpGaD
Flurazepam—CYP3A4—Biological oxidations—POMC—kidney cancer	1.75e-05	0.000228	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—LDHB—kidney cancer	1.73e-05	0.000225	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—BCHE—kidney cancer	1.72e-05	0.000224	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SCARB1—kidney cancer	1.72e-05	0.000223	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.71e-05	0.000222	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.7e-05	0.000221	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS1—kidney cancer	1.7e-05	0.000221	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CRABP1—kidney cancer	1.69e-05	0.00022	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PSMD7—kidney cancer	1.67e-05	0.000217	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CCBL1—kidney cancer	1.65e-05	0.000215	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000214	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.64e-05	0.000214	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—BCHE—kidney cancer	1.58e-05	0.000206	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ITPR2—kidney cancer	1.57e-05	0.000205	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.57e-05	0.000204	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.56e-05	0.000203	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.55e-05	0.000202	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.51e-05	0.000197	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.51e-05	0.000196	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CA9—kidney cancer	1.5e-05	0.000195	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.48e-05	0.000192	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTT1—kidney cancer	1.43e-05	0.000187	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ACHE—kidney cancer	1.43e-05	0.000187	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.43e-05	0.000186	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PPAT—kidney cancer	1.43e-05	0.000186	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.4e-05	0.000182	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTP1—kidney cancer	1.37e-05	0.000178	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SCARB1—kidney cancer	1.36e-05	0.000177	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS1—kidney cancer	1.34e-05	0.000175	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—APRT—kidney cancer	1.33e-05	0.000173	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—FH—kidney cancer	1.33e-05	0.000173	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PSMD7—kidney cancer	1.32e-05	0.000171	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ABCB1—kidney cancer	1.3e-05	0.000169	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.28e-05	0.000167	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CRABP1—kidney cancer	1.27e-05	0.000166	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000164	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTP1—kidney cancer	1.26e-05	0.000164	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPC3—kidney cancer	1.25e-05	0.000163	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—BCHE—kidney cancer	1.25e-05	0.000163	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.24e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.23e-05	0.000161	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CA2—kidney cancer	1.22e-05	0.000158	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000155	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.19e-05	0.000155	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ABCB1—kidney cancer	1.19e-05	0.000155	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALAD—kidney cancer	1.19e-05	0.000154	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ITPR2—kidney cancer	1.18e-05	0.000154	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.16e-05	0.000151	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GSTM1—kidney cancer	1.16e-05	0.00015	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.13e-05	0.000147	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000143	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.08e-05	0.000141	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PGK1—kidney cancer	1.08e-05	0.000141	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ACHE—kidney cancer	1.08e-05	0.00014	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTT1—kidney cancer	1.08e-05	0.00014	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—LDHB—kidney cancer	1.06e-05	0.000138	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SCARB1—kidney cancer	1.02e-05	0.000133	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS1—kidney cancer	1.01e-05	0.000132	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTP1—kidney cancer	9.93e-06	0.000129	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PSMD7—kidney cancer	9.92e-06	0.000129	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ABCB1—kidney cancer	9.4e-06	0.000122	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—BCHE—kidney cancer	9.4e-06	0.000122	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC5A5—kidney cancer	9.29e-06	0.000121	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CA9—kidney cancer	9.22e-06	0.00012	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GSTM1—kidney cancer	9.13e-06	0.000119	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SLC2A1—kidney cancer	8.97e-06	0.000117	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—POMC—kidney cancer	8.89e-06	0.000116	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CYP1A1—kidney cancer	8.65e-06	0.000113	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.55e-06	0.000111	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—POMC—kidney cancer	8.16e-06	0.000106	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CRABP1—kidney cancer	7.84e-06	0.000102	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTP1—kidney cancer	7.48e-06	9.74e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ITPR2—kidney cancer	7.29e-06	9.49e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTGS2—kidney cancer	7.09e-06	9.23e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GSTM1—kidney cancer	6.87e-06	8.95e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTT1—kidney cancer	6.65e-06	8.66e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ACHE—kidney cancer	6.65e-06	8.66e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CYP1A1—kidney cancer	6.52e-06	8.48e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTGS2—kidney cancer	6.51e-06	8.48e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—POMC—kidney cancer	6.45e-06	8.4e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SCARB1—kidney cancer	6.29e-06	8.19e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS1—kidney cancer	6.23e-06	8.11e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PTEN—kidney cancer	6.19e-06	8.05e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PSMD7—kidney cancer	6.11e-06	7.95e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—BCHE—kidney cancer	5.79e-06	7.54e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.72e-06	7.45e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PTEN—kidney cancer	5.68e-06	7.39e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.53e-06	7.19e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTGS2—kidney cancer	5.15e-06	6.7e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—POMC—kidney cancer	4.86e-06	6.32e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTP1—kidney cancer	4.61e-06	6e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PTEN—kidney cancer	4.49e-06	5.84e-05	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—PIK3CA—kidney cancer	4.36e-06	5.68e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ABCB1—kidney cancer	4.36e-06	5.68e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GSTM1—kidney cancer	4.24e-06	5.51e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.01e-06	5.23e-05	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—PIK3CA—kidney cancer	4.01e-06	5.22e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTGS2—kidney cancer	3.88e-06	5.04e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PTEN—kidney cancer	3.38e-06	4.4e-05	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—PIK3CA—kidney cancer	3.17e-06	4.12e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—POMC—kidney cancer	2.99e-06	3.9e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTGS2—kidney cancer	2.39e-06	3.11e-05	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—PIK3CA—kidney cancer	2.38e-06	3.1e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PTEN—kidney cancer	2.08e-06	2.71e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.47e-06	1.91e-05	CbGpPWpGaD
